GlassScriptPhysician profile
Jeffrey Hofman
NPI 1770638900
$1,469.83
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $652 · 2020: $106 · 2021: $199 · 2022: $476 · 2023: $35.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $35.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $35.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $368.65 | 2019-2022 | |
| Therapeuticsmd, INC. | $323.34 | 2019-2022 | |
| Avanos Medical | $110.83 | 2019-2020 | |
| Medtronic, INC. | $97.85 | 2021-2022 | |
| Exeltis, USA INC. | $83.56 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $82.58 | 2022-2023 | |
| Myovant Sciences INC. | $60.53 | 2021-2022 | |
| Scynexis, INC. | $57.84 | 2022 | |
| Avion Pharmaceuticals | $39.70 | 2019-2021 | |
| Evofem Biosciences, INC. | $29.97 | 2021-2022 | |
| Coopersurgical, INC. | $29.95 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $27.44 | 2019 | |
| Agile Therapeutics, INC. | $27.26 | 2021-2022 | |
| Ge Healthcare | $22.38 | 2019 | |
| Organon LLC | $20.47 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $18.40 | 2019 | |
| Glaxosmithkline, LLC. | $15.25 | 2020 | |
| Pfizer INC. | $15.00 | 2019 | |
| Sanofi Pasteur INC. | $14.93 | 2019 | |
| Astellas Pharma US INC | $12.59 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.31 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Hofman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.